Spitsyn A F
Med Radiol (Mosk). 1988 Aug;33(8):15-20.
The paper is devoted to a cooperative study of comparative assessment of the efficacy of 3 dose fractionation regimens in intracavitary gamma-therapy used in combined radiation therapy of cervical cancer (5 Gy, 10 fractions, 2-3 times a week; 7 Gy, 7 fractions, once in 5 days; 10 Gy, 4 fractions, once a week). Over the period of 1979-1983 1193 patients were treated by uniform methods of intracavitary and distant irradiation. The groups were identical with relation to the number of patients, stage of disease, histological characterization and growth type. By the end of therapy the cure rate among 1183 patients was 90.3%. In 2-3 months the cure rate in the same group was 97.5%. Delayed regression was most noticeable in stages II and III. The 5-year survival rates in 3 groups were: for stage I-95.3 +/- 2.6%; for stage II-83.1 +/- 2.5%; for stage III-73.3 +/- 4.7%. In stage I and II tumors the 5-year survival rates in different regimens were similar whereas in stage III better results were obtained with a fractional dose of 5 Gy. The frequency and degree of severity of late radiation complications of the rectum, bladder, vaginal mucous membrane grew with an increase in a fractional dose.
本文致力于对宫颈癌综合放射治疗中腔内伽马治疗的3种剂量分割方案疗效进行比较评估的合作研究(5 Gy,10次分割,每周2 - 3次;7 Gy,7次分割,每5天1次;10 Gy,4次分割,每周1次)。在1979 - 1983年期间,1193例患者接受了腔内和远距离照射的统一方法治疗。各组在患者数量、疾病分期、组织学特征和生长类型方面相同。治疗结束时,1183例患者的治愈率为90.3%。在2 - 3个月时,同一组的治愈率为97.5%。延迟消退在II期和III期最为明显。3组的5年生存率分别为:I期 - 95.3 +/- 2.6%;II期 - 83.1 +/- 2.5%;III期 - 73.3 +/- 4.7%。在I期和II期肿瘤中,不同方案的5年生存率相似,而在III期,分次剂量为5 Gy时取得了更好的结果。直肠、膀胱、阴道黏膜晚期放射并发症的发生率和严重程度随着分次剂量的增加而增加。